Stefano Rusconi

46PUBLICATIONS
170CO-AUTHORS
PharmacogenomicsInnate immunityMedical molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)Digital and electronic media art
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|May 15, 2026
'Leaving no stones unturned': up to 10 years results on the effectiveness, tolerability and metabolic safety of dolutegravir+lamivudine (DTG+3TC) as a switch regimen in the ODOACRE cohort.

|Mar 18, 2026
Early Combination Antiretroviral Therapy Initiation During Primary HIV Infection Restricts HIV Reservoirs and Gut-Driven Inflammation but Fails to Rewire the Systemic Cytokine Landscape.

Valeria Bono, Camilla Tincati, Matteo Augello

|Feb 24, 2026
Switching to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and prior resistance mutations. Data from the Italian ARCA cohort: the BIC-BARRIER study. B/F/TAF switch: mutations and outcomes.

Laura Pezzati, Federico Conti, William Gennari

|Jun 26, 2025
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort.

Roberta Gagliardini, Sara De Benedittis, Alessandro Tavelli

|Feb 12, 2025
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era.

Annalisa Bergna, Alessia Lai, Fabio Sagradi

|Dec 02, 2024
Predictors for choosing doravirine-based versus INSTI-based regimen in ART-naïve and ART-experienced people with HIV in real-world setting: Data from the Icona cohort.

Antonella d'Arminio Monforte, Alessandro Tavelli, Eugenia Quiros-Roldan

Pageof 8

Frequent Collaborators

12 joint publications

Andrea Giacomelli

7 joint publications

Antonio Di Biagio

5 joint publications

Gabriele Pagani

4 joint publications

Arturo Ciccullo